Hepatic encephalopathy (HE) is a common and complex neuropsychiatric syndrome seen in patients with liver failure. It is characterized by neuropsychiatric disturbances in consciousness and behavior, ...

Rifaximin is a non-systemic oral antibiotic derived from rifampin and characterized by a broad spectrum of antibacterial activity against Gram-positive and -negative, aerobic and anaerobic bacteria.

Rifaximin is available as 2 licensed products, both of which are licensed for use in people aged 18 years and older: Rifaximin is not licensed for the treatment of pouchitis and its use for this ...

Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data ...

One small randomised controlled trial (RCT) and 2 small non-comparative observational studies provide limited evidence that rifaximin alone or in combination with ciprofloxacin can improve symptoms or ...

Learn everything you need to know about Rifaximin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Please provide your email address to receive an email when new articles are posted on . Low-dose rifaximin plus N-acetylcysteine was superior to rifaximin alone, with significant improvements in ...

Over 6 months, 23.2% of patients receiving rifaximin monotherapy experienced an OHE breakthrough episode compared with 49% of patients receiving lactulose monotherapy (P<0.0001), reported Jasmohan S.